Association between DHEAS and bone loss in postmenopausal women: A 15-year longitudinal population-based study

Calcified Tissue International

Volumn 89, Issue 4, 2011, Pages 295-302

  Ghebre, Michael A ^a   Hart, Deborah J ^a   Hakim, Alan J ^b   Kato, Bernet S ^c   Thompson, Vicky ^b   Arden, Nigel K ^d   Spector, Tim D ^a   Zhai, Guangju ^a,e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

BMD; DHEAS; Longitudinal study; Osteoporosis; Postmenopausal

Indexed keywords

ESTRADIOL; PRASTERONE SULFATE;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BONE DENSITY; COHORT ANALYSIS; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FOLLOW UP; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; LONGITUDINAL STUDY; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOIMMUNOASSAY;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; FEMUR NECK; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POPULATION; POSTMENOPAUSE; TIME FACTORS;

EID: 82755197946     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-011-9518-9     Document Type: Article

References (31)

1. -(1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646-650
2. Kanis JA, Brazier JE, Stevenson M, Calvert NW, Lloyd Jones M (2002) Treatment of established osteoporosis: a systematic review and cost-utility analysis. Health Technol Assess 6:1-146
3. Asomaning K, Bertone-Johnson ER, Nasca PC, Hooven F, Pekow PS (2006) The association between body mass index and osteoporosis in patients referred for a bone mineral density examination. J Womens Health (Larchmt) 15:1028-1034 (Pubitemid 46381777)
4. Ray NF, Chan JK, Thamer M, Melton LJ 3rd (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12:24-35 (Pubitemid 27053608)
5. Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N (2005) Assessment of fracture risk. Osteoporos Int 16:581-589 (Pubitemid 40897454)
6. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Scott J, Vogt TM (1993) Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 341:72-75 (Pubitemid 23028113)
7. Guthrie JR, Ebeling PR, Hopper JL, Barrett-Connor E, Dennerstein L, Dudley EC, Burger HG, Wark JD (1998) A prospective study of bone loss in menopausal Australian-born women. Osteoporos Int 8:282-290 (Pubitemid 28427079)
8. Leowattana W (2001) DHEA(S): the fountain of youth. J Med Assoc Thai 84(Suppl 2):S605-S612 (Pubitemid 34415192)
9. Labrie F, Belanger A, Luu-The V, Labrie C, Simard J, Cusan L, Gomez JL, Candas B (1998) DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids 63:322-328 (Pubitemid 28265670)
10. Barrett-Connor E, Kritz-Silverstein D, Edelstein SL (1993) A prospective study of dehydroepiandrosterone sulfate (DHEAS) and bone mineral density in older men and women. Am J Epidemiol 137:201-206 (Pubitemid 23083672)
11. Lambrinoudaki I, Christodoulakos G, Aravantinos L, Antoniou A, Rizos D, Chondros C, Kountouris A, Chrysofakis G, Creatsas G (2006) Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women. J Bone Miner Metab 24:65-71 (Pubitemid 41821506)
12. Osmanagaoglu MA, Okumus B, Osmanagaoglu T, Bozkaya H (2004) The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women. J Womens Health (Larchmt) 13:993-999 (Pubitemid 40017337)
13. Spector TD, Thompson PW, Perry LA, McGarrigle HH, Edwards AC (1991) The relationship between sex steroids and bone mineral content in women soon after the menopause. Clin Endocrinol (Oxf) 34:37-41
14. Sun AJ, Jing T, Heymsfield SB, Phillips GB (2003) Relationship of leptin and sex hormones to bone mineral density in men. Acta Diabetol 40(Suppl 1):S101-S105 (Pubitemid 37322730)
15. Bacsi K, Kosa JP, Borgulya G, Balla B, Lazary A, Nagy Z, Horvath C, Speer G, Lakatos P (2007) CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women. Calcif Tissue Int 80:154-159 (Pubitemid 46411881)
16. Hart DJ, Spector TD (1993) The relationship of obesity, fat distribution and osteoarthritis in women in the general population: the Chingford Study. J Rheumatol 20:331-335 (Pubitemid 23066048)
17. Zhai G, Hart DJ, Valdes AM, Kato BS, Richards JB, Hakim A, Spector TD (2008) Natural history and risk factors for bone loss in postmenopausal Caucasian women: a 15-year follow-up population- based study. Osteoporos Int 19:1211-1217
18. Wathen NC, Perry LA, Rubenstein E, Chard T (1987)Arelationship between sex hormone binding globulin and dehydroepiandrosterone sulfate in normally menstruating females. Gynecol Endocrinol 1:47-50
19. Tok EC, Ertunc D, Oz U, Camdeviren H, Ozdemir G, Dilek S (2004) The effect of circulating androgens on bone mineral density in postmenopausal women. Maturitas 48:235-242 (Pubitemid 38786464)
20. Khosla S, Melton LJ 3rd, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL (1998) Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 83:2266-2274 (Pubitemid 28503012)
21. Szathmari M, Szucs J, Feher T, Hollo I (1994) Dehydroepiandrosterone sulphate and bone mineral density. Osteoporos Int 4:84-88 (Pubitemid 24103700)
22. Zofkova I, Bahbouh R, Hill M (2000) The pathophysiological implications of circulating androgens on bone mineral density in a normal female population. Steroids 65:857-861
23. Murphy S, Khaw KT, Sneyd MJ, Compston JE (1992) Endogenous sex hormones and bone mineral density among communitybased postmenopausal women. Postgrad Med J 68:908-913
24. Guthrie JR, Lehert P, Dennerstein L, Burger HG, Ebeling PR, Wark JD (2004) The relative effect of endogenous estradiol and androgens on menopausal bone loss: a longitudinal study. Osteoporos Int 15:881-886 (Pubitemid 39506454)
25. Villareal DT, Holloszy JO, Kohrt WM (2000) Effects of DHEA replacement on bone mineral density and body composition in elderly women and men. Clin Endocrinol (Oxf) 53:561-568
26. Arlt W, Haas J, Callies F, Reincke M, Hubler D, Oettel M, Ernst M, Schulte HM, Allolio B (1999) Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens. J Clin Endocrinol Metab 84:2170-2176 (Pubitemid 30647050)
27. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 15:1526-1536 (Pubitemid 30484522)
28. Wang C, Eyre DR, Clark R et al (1996) Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men - a clinical research center study. J Clin Endocrinol Metab 81:3654-3662 (Pubitemid 26339933)
29. Martel C, Sourla A, Pelletier G, Labrie C, Fournier M, Picard S, Li S, Stojanovic M, Labrie F (1998) Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat. J Endocrinol 157:433-442 (Pubitemid 28275842)
30. Cutler GB, Glenn M, Bush M, Hodgen GD, Graham CE, Loriaux DL (1978) Adrenarche - survey of rodents, domestic animals, and primates. Endocrinology 103:2112-2118 (Pubitemid 9075949)
31. Haren MT, Malmstrom TK, Banks WA, Patrick P, Miller DK, Morley JE (2007) Lower serum DHEAS levels are associated with a higher degree of physical disability and depressive symptoms in middle-aged to older African American women. Maturitas 57:347-360 (Pubitemid 47048600)